Coya Therapeutics, Inc. (COYA) vs vTv Therapeutics Inc. (VTVT)

Coya Therapeutics, Inc. and vTv Therapeutics Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and vTv Therapeutics Inc. are of similar size ($121.5M and $121.5M). vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against 108.4%. vTv Therapeutics Inc. has the higher net margin (0.00% vs −270.2%) and the higher return on invested capital (0.00% vs −15,230.9%). Across the 16 metrics below, vTv Therapeutics Inc. leads on 12 and Coya Therapeutics, Inc. on 4.

Valuation

Metric COYA VTVT Biotechnology median
P/E n/m n/m 7.88
P/S 14.95 9.90 11.47
P/B 2.77 4.77 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 11.18 7.62 10.73
Earnings yield (20.94%) (2.55%) (28.84%)
Free cash flow yield (14.83%) (4.50%) (23.03%)

Profitability

Metric COYA VTVT Biotechnology median
Gross margin 100.00% 99.92% 65.16%
Operating margin (288.70%) 0.00% 0.00%
Net margin (270.22%) 0.00% 0.00%
Free cash flow margin (221.64%) 0.00% 0.00%
Return on equity (60.54%) (11.74%) (57.72%)
Return on assets (53.66%) (8.34%) (49.22%)
Return on invested capital (15,230.92%) 0.00% 0.00%

Growth

Metric COYA VTVT Biotechnology median
Revenue growth (TTM) 108.35% 654.58% 5.64%
EPS growth (last fiscal year) (29.59%) 0.00% —
Revenue growth, 5-year CAGR — (39.39%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 12.48 4.73
Net debt to EBITDA 2.08 2.71 0.96

Dividend

Metric COYA VTVT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric COYA VTVT Biotechnology median
Market cap 121.51m 121.51m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack